Skip to main content

ETFs Basics (3) continued

By Rick Walter

An ETF, like any other type of investment company, will have a prospectus. All investors that purchase Creation Units receive a prospectus. Some ETFs also deliver a prospectus to secondary market purchasers. ETFs that do not deliver a prospectus are required to give investors a document known as a Product Description, which summarizes key information about the ETF and explains how to obtain a prospectus. All ETFs will deliver a prospectus upon request. Before purchasing ETF shares, you should carefully read all of an ETF’s available information, including its prospectus.

The websites of the New York Stock Exchange, American Stock Exchange and NASDAQ provide more information about different types of ETFs and how they work. An ETF will have annual operating expenses and may also impose certain shareholders fees that are disclosed in the prospectus.

Currently, all ETFs seek to achieve the same return as a particular market indexes. Such an ETF is similar to an index fund in that it will primarily invest in the securities of companies that are included in a selected market index. An ETF will invest in either all of the securities or a representative sample of the securities included in the index. For example, one type of ETF, known as Spiders or SPDRs, invests in all of the stocks contained in the S&P 500 Composite Stock Price Index. http://www.sec.gov/answers/etf.htm

There are 4 Sectors/Industries that I am currently monitoring: Energy, Financials, Health care, Commercial Real Estate, and Treasuries and cash. However, one of my concerns is the growing proliferation of sponsors of ETFs, the indexes that they track for benchmarking, investors setting performance expectations on ETFs too high or using them as a cure-all for individual portfolio ills. I will delve into these problems and more as I continue to bring more information on ETF investing and my experience investing in them.

Comments

Popular posts from this blog

Morning Update

By Rick Walter Still working on putting together a strong biotech portfolio. Here is a good general article on the state of the biotech industry that was posted yesterday on the online Wall Street Journal's site- Biotech Stocks Hot Right Now, Ho-Hum in the Long Run.

Portfolio Update

By Rick Walter I have posted a new Biotechnology portfolio . It's total return as of November 25, 2009 is 3.4%. However, to download and use it you will have to subscribe to the portfolio, of course. On an important note, I consider each portfolio to be well diversified in its particular sector but I've recently decided to add stock futures and options positions to each portfolio which will increase each portfolio's return but lower the risks going forward.

New Podcast Series

By Rick Walter Hi everyone! Tune-in to our new financial commentary podcast(audio) series . The goal of our podcast is to help you cut through the clutter of web misinformation by focusing in on specific articles that can help you make timely decision on companies that you may own as investments. The ongoing series will also provide independent analysis on specific industries, and cover important topics that unfold daily with input from heads of local and regional companies that are private and publicly traded. Tune in daily at http://www.ucsinv1.podomatic.com/ .